Beyond Bulls & Bears

Templeton Global Macro: An Update on our ESG Scores
Fixed Income

Templeton Global Macro: An Update on our ESG Scores

Templeton Global Macro evaluates environmental, social and governance (ESG) factors in its macroeconomic research process and describes the process of codifying the team’s research discussions into quantifiable scores.

Health Care Sector Innovation: How Biopharma Scientists Save Lives Globally
Equity

Health Care Sector Innovation: How Biopharma Scientists Save Lives Globally

In today’s world of disruptive innovations, biotechnology is entering the most transformative phase our health care analysts have seen in 25 years. Since mapping out the human genome in 2003, drugs using new treatment paradigms—like gene and cellular therapies—have jumped out of laboratories and into the marketplace to tackle humanity’s most vexing diseases.

Hasenstab: Focus on Fundamentals in US, Emerging Markets
Fixed Income

Hasenstab: Focus on Fundamentals in US, Emerging Markets

“If you have a three-month time horizon, EM investing is very difficult. If you have a couple-year horizon, you can exploit these panic sell-offs that are not fundamental in nature.” - Michael Hasenstab

India’s Reform Movement Gains Momentum
Fixed Income

India’s Reform Movement Gains Momentum

Templeton Global Macro CIO Michael Hasenstab recently visited India, and takes a look at some of the reforms he’s most excited about as a global fixed-income investor. He believes India’s future looks bright and that its growth trajectory should remain strong—despite some short-term adjustments.

How India Is Stepping Out of China’s Shadow
Emerging Markets

How India Is Stepping Out of China’s Shadow

In 2015, India’s gross domestic product growth surpassed that of China, and forecasters generally expect India’s growth to remain robust in 2016. ...

New Year’s Vantage Point: Mark Mobius

New Year’s Vantage Point: Mark Mobius